Developing Breakthrough Therapy to Reverse Disability After Stroke

Novel, AI-powered, tailored electromagnetic stimulation aimed to help you achieve freedom from disability following a stroke from the comfort of your home

Learn More

Proud to collaborate with esteemed research and medical institutions

1 in 4

Adults will experience a stroke in their lifetime*

1 in 4 adults image

* Feigin, Valery L., et al. "World Stroke Organization (WSO): global stroke fact sheet 2022." International Journal of Stroke 17.1 (2022): 18-29

** Lee, Kyoung Bo, et al. "Six-month functional recovery of stroke patients: a multi-time-point study." International journal of rehabilitation research 38.2 (2015): 173-180

60%

of stroke survivors face life-debilitating long-term disability**

Re
habilitation
verse

‘Freedom From Disability’ is the ultimate goal for stroke survivors

Person drinking Coffee at home
Independence at Home
happy elderly woman
Returning to Work
a senior woman with her grandchild
Family Time
senior male playing basketball
Hobbies

Our investigational therapy has already demonstrated promising results in regaining 'freedom from disability' in well-designed studies

Learn More
a family around dinner table

Granted FDA Breakthrough Device Designation
Investigational Device designed for safe use wherever you are, in the clinic or at home.

BrainQ products

Brain Relearning. Reimagined with AI. 

Reversing stroke disability requires the brain's neural networks to relearn lost functions.

BRAIN.Q relies on emerging science suggesting the use of targeted stimulation of network activity as a key for maximizing the brain's learning capabilities.

Our breakthrough investigational therapy is designed to use AI to distill neural activity patterns by analyzing datasets of network activity.

These patterns are then applied to patients through tailored, low-intensity, low frequency electromagnetic stimulation that aims to enhance and accelerate the brain's recovery process after stroke.

Learn More
Elderly person with BrainQ Equipment

Defying Stroke Takes Real Bravery

No two journeys to recovery are the same. Our investigational therapy is designed to support our heroes on their individual paths, every step of the way, whether they are in the clinic or at home.

Learn more about the patient experience from our first participant in our EMAGINE clinical trial

“The main thing is that I was able to be at home and take care of him the way he needed to be taken care of”

Daughter of stroke survivor
EMAGINE Study Participant

“[BRAIN.Q] gave me something to look forward to every day”

Stroke survivor
EMAGINE Study Participant

“…was very user friendly, very easy to use… I would recommend it to anybody”

Stroke survivor
EMAGINE Study Participant

"[Patients have] said they were so lucky to have BRAIN.Q or they would have been home doing nothing and wasting recovery time... [EMAGINE] made them feel like they were not alone in this recovery process"

EMAGINE Study Clinical Site Therapist

Awards & Recognition

BRAIN.Q named Technology Pioneer in the World Economic Forum's 2024 Cohort

Granted FDA Breakthrough Device Designation

Recognized as a "ground-breaking" innovation and received funding from the European Union’s Horizon 2020 research and innovation program

BRAIN.Q Named to Fast Company's "Next Big Things in Tech" list

Named one of the most promising startups in Israel by Calcalist and Microsoft in 2018

IBM Alpha Zone Accelerator

One of four startups invited to participate in Google Developers Launchpad Studio's AI program

2nd place in the AI category in the China (Shenzen) Int. Innovation & Entrepreneurship International Competition

BRAIN.Q named "Best New Technology Solution - Therapeutic" in the 2024 Medtech Breakthrough Awards

Quest for Brain Health

As we age, brain health emerges as the greatest challenge for each of us.

BRAIN.Q symbolizes our devotion to navigating this quest with humility and persistence, with the goal of enhancing brain health.

As the first steps in this quest, BRAIN.Q has successfully conducted several clinical and preclinical studies in a variety of neurological conditions with the goal of improving patient outcomes.

From the News

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.